PMC483056_01
Axial T1-weighted fluid-attenuated inversion recovery (FLAIR) MRI images showing confluent demyelination. MRIs were taken at 10 months (left) and at 18 months (right) after initiation of treatment with pioglitazone. Similar axial sections are shown for the two time points.
1742-2094-1-3-1.jpg
PMC483056_01_1742-2094-1-3-1.jpg
F1
During the study, two MRI studies with gadolinium (Gd) were performed, one 18 months after initiation of pioglitazone and the second 10 months later (Figure 1).